Immunotherapy
A case of immune-related adverse events, thyroid dysfunction, myocarditis with myositis, and myasthenia gravis overlap syndrome following serplulimab administration for lung adenocarcinoma.
Xiaoliang Li, Qi Feng, Yuan Yu, Xudong Zhao, Pengxi Wang, Dafu Tang, Hailiang Yu
Published: 202610.1080/1750743X.2026.2619654
Abstract
BACKGROUND: Serplulimab is an immune checkpoint inhibitor (ICI) that blocks inhibitors, augmenting anti-tumor immunity but also carrying risks of immune-related adverse events (irAEs). While neuromuscular and cardiac toxicities are rare, their co-occ…
Preview only. Read the full abstract at the source